Cardiometabolic features of polycystic ovary syndrome

被引:0
|
作者
Leslie K Hoffman
David A Ehrmann
机构
[1] LK Hoffman is a Fellow,Department of Medicine
[2] and DA Ehrmann is a Professor of Medicine,undefined
[3] in the Section of Endocrinology,undefined
[4] Diabetes and Metabolism,undefined
[5] University of Chicago,undefined
[6] Chicago,undefined
[7] IL,undefined
[8] USA.,undefined
来源
Nature Clinical Practice Endocrinology & Metabolism | 2008年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Polycystic ovary syndrome (PCOS) affects up to 10% of women and features a range of hormonal and metabolic abnormalities, many of which are associated with increased cardiovascular risk. The authors of this article urge clinicians to be aware of this risk when dealing with even young women who have PCOS.
引用
收藏
页码:215 / 222
页数:7
相关论文
共 50 条
  • [31] Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome
    Cussons, Andrea J.
    Watts, Gerald F.
    Burke, Valerie
    Shaw, Jonathan E.
    Zimmet, Paul Z.
    Stuckey, Bronwyn G. A.
    HUMAN REPRODUCTION, 2008, 23 (10) : 2352 - 2358
  • [32] A Unique Rodent Model of Cardiometabolic Risk Associated with the Metabolic Syndrome and Polycystic Ovary Syndrome
    Shi, Danni
    Dyck, Michael K.
    Uwiera, Richard R. E.
    Russell, Jim C.
    Proctor, Spencer D.
    Vine, Donna F.
    ENDOCRINOLOGY, 2009, 150 (09) : 4425 - 4436
  • [33] The prevalence and features of the polycystic ovary syndrome in an unselected population
    Azziz, R
    Woods, KS
    Reyna, R
    Key, TJ
    Knochenhauer, ES
    Yildiz, BO
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06): : 2745 - 2749
  • [34] The association of the lipidomic profile with features of polycystic ovary syndrome
    Moran, L. J.
    Mundra, P. A.
    Teede, H. J.
    Meikle, P. J.
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2017, 59 (01) : 93 - 104
  • [35] Mercury leads to features of polycystic ovary syndrome in rats
    Merlo, Eduardo
    Schereider, Ingridy R. G.
    Simoes, Maylla R.
    Vassallo, Dalton V.
    Graceli, Jones B.
    TOXICOLOGY LETTERS, 2019, 312 : 45 - 54
  • [36] What are the key features of importance in polycystic ovary syndrome?
    Lobo, RA
    FERTILITY AND STERILITY, 2003, 80 (02) : 259 - 261
  • [37] Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome
    Zhu, Jia
    Eliasen, Anders U.
    Aris, Izzuddin M.
    Stinson, Sara E.
    Holm, Jens-Christian
    Hansen, Torben
    Hivert, Marie-France
    Bonnelykke, Klaus
    Salem, Rany M.
    Hirschhorn, Joel N.
    Chan, Yee-Ming
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (02): : 380 - 388
  • [38] Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
    Moran, Lisa
    Teede, Helena
    HUMAN REPRODUCTION UPDATE, 2009, 15 (04) : 477 - 488
  • [39] Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome
    Krysiak, Robert
    Kowalcze, Karolina
    Okopien, Boguslaw
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (09): : 1045 - 1052
  • [40] The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome
    Krysiak, Robert
    Kowalcze, Karolina
    Okopien, Boguslaw
    PHARMACOLOGY, 2023, 108 (05) : 451 - 459